Published in
American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(32), p. 3589-3589, 2014
DOI: 10.1200/jco.2014.32.15_suppl.3589
Links
Tools
Four-year survival in patients (pts) undergoing liver surgery after neoadjuvant triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) for previously treated and unresectable liver metastases from kras wt colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228).
Journal article published in 2014 by
Francis Levi,
Michel Ducreux,
Denis Michel Smith,
Mohamed Hebbar,
Céline Lepère,
C. N. J. Focan,
Rosine Guimbaud,
Pasquale F. Innominato,
Carlos Carvalho,
Salvatore Tumolo,
Stephanie Truant 
,
Denis Castaing,
Abdoulaye Karaboué,
Valerie Boige,
Mohamed Bouchahda
and other authors.
,
Denis Castaing,
Abdoulaye Karaboué,
Valerie Boige,
Mohamed Bouchahda
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 